Physical and chemical analysis of epimedii herba by the packaging methods and storage periods
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seo C.-S. | - |
dc.contributor.author | Kim J.-H. | - |
dc.contributor.author | Lee S. | - |
dc.contributor.author | Kim S.-S. | - |
dc.contributor.author | Kim S.-M. | - |
dc.contributor.author | Shin H.-K. | - |
dc.date.available | 2020-03-03T12:42:57Z | - |
dc.date.created | 2020-02-24 | - |
dc.date.issued | 2019-12 | - |
dc.identifier.issn | 0253-3073 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/19465 | - |
dc.description.abstract | In order to obtain basic data on the shelf life of Epimedii Herba (EH), a physicochemical characteristics including weight loss rate, loss on drying, ash, acid-insoluble ash, and quantitative determination were evaluated to compare the data by packaging methods including general (G), general + silica gel (GS), alumium (AL), and alumium + silica gel (ALS) packaging and storage periods (0−66 months). All physicochemical analyzes were conducted using the method of “The Korean Pharmacopoeia (KP) 9th edition”. As a result, weight loss rate (%), loss on drying (%), ash (%), acid-insoluble ash (%) of EH according to the packaging methods and storage periods were-0.27-4.73%, 3.06-9.35%, 5.48-7.37%, and 0.45-0.99, respectively. In the quantitative analysis of icariin, the marker compound of EH using high-performance liquid chromatography, the initial content was 0.44% at 0 month in all packaging methods. After that, the result of analyzing the content of icariin every 6 months was detected 0.44-1.18%. All of the above results satisfied the acceptance criteria for loss on drying, ash, acid-insoluble ash, and quantification contained in the KP. This study can be used as a basic data for establishing the packaging method and shelf life of EH. © 2019, Korean Society of Pharmacognosy. All rights reserved. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | Korean Society of Pharmacognosy | - |
dc.relation.isPartOf | Korean Journal of Pharmacognosy | - |
dc.title | Physical and chemical analysis of epimedii herba by the packaging methods and storage periods | - |
dc.title.alternative | 포장방법 및 보관기간에 따른 음양곽의 이화학적 분석 | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | Korean Journal of Pharmacognosy, v.50, no.4, pp.312 - 317 | - |
dc.identifier.kciid | ART002539366 | - |
dc.identifier.scopusid | 2-s2.0-85078719942 | - |
dc.citation.endPage | 317 | - |
dc.citation.startPage | 312 | - |
dc.citation.title | Korean Journal of Pharmacognosy | - |
dc.citation.volume | 50 | - |
dc.citation.number | 4 | - |
dc.contributor.affiliatedAuthor | Lee S. | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Epimedii Herba | - |
dc.subject.keywordAuthor | Icariin | - |
dc.subject.keywordAuthor | Packaging method | - |
dc.subject.keywordAuthor | Storage period | - |
dc.subject.keywordPlus | herbaceous agent | - |
dc.subject.keywordPlus | icariin | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | ash | - |
dc.subject.keywordPlus | chemical analysis | - |
dc.subject.keywordPlus | Chinese medicine | - |
dc.subject.keywordPlus | drug packaging | - |
dc.subject.keywordPlus | drug storage | - |
dc.subject.keywordPlus | high performance liquid chromatography | - |
dc.subject.keywordPlus | physical chemistry | - |
dc.subject.keywordPlus | shelf life | - |
dc.subject.keywordPlus | tablet weight | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.